Gan & Lee Pharmaceuticals Hits Day High with Strong 4.33% Intraday Surge

Gan & Lee Pharmaceuticals Co., Ltd. has experienced a notable uptick in its stock performance, gaining 4.33% on June 2, 2026. The stock reached an intraday high of CNY 55.36, reflecting a strong day of trading activity. This performance stands in contrast to the China Shanghai Composite, which only saw a modest increase of 0.43% on the same day. Over the past week, Gan & Lee has shown a positive trend with a 2.52% increase, while the broader market has declined by 1.7%. However, the company’s performance over the past month has been less favorable, with a decrease of 6.56%. Year-to-date, the stock has faced challenges, down 19.22%, despite a robust annual return of 37.52%, significantly outperforming the market's 22.49% return. Financially, Gan & Lee reported net sales of CNY 2,062.17 million, marking a 23% growth, and has maintained positive results for the last eight consecutive quarters. The company’s return on equity stands at 8.40%, with a dividend yield of 1.88%, indicating a solid financial position within the pharmaceuticals and biotechnology industry.